ABSTRACT: Regenerative medicine and tissue engineering studies are actively developing novel means to repair adult articular cartilage defects using biological approaches. One such approach is the harnessing of adult human therapeutic cells such as those referred to as mesenchymal stem cells. Upon exposure to chondrogenic signals, these cells differentiate and initiate the production of a complex and voluminous cartilaginous matrix that is crucial to both the structure and function of cartilage. Furthermore, this complexity requires the time-sensitive activation of a large number of genes to produce the components of this matrix. The current study analyzed the kinetics of matrix production in an aggregate culture model where adult human mesenchymal stem cells were induced to differentiate as chondrocytes. The results indicate the existence of a biphasic mode of differentiation and maturation during which matrix genes and molecules are differentially activated and secreted. These results have important implications for developing novel approaches for the creation of tissue engineered articular cartilage. ß
Cartilage is a unique tissue in which a relatively small population of cells produce an elaborate and extensive extracellular matrix (ECM). 1, 2 The development and maturation of this tissue on long bones occurs in multiple stages where cell-cell and cell-matrix interactions combine to regulate elongation of these bones, a process that culminates in the formation of articular surfaces at the ends of these bones. 1 This articulation is critical for joint movement and depends upon a unique cellular population and a site-specific, functional ECM. 3 The extensive matrix that surrounds chondrocytes consists of two essential components, proteoglycans (PGs) and collagens. 2, 4 Additional components regulate the assembly of collagenous fibers and provide physical connections between these fibers and highly sulfated PGs. 2 In combination, these two sets of matrix components provide for the strength and compressive functions that are characteristic of this tissue. 4 Replacement of this ECM is a current goal of regenerative medicine.
The ECM plays a central role in the development of most tissues, no more so than for cartilage. 5 The initiation of cartilage development in vivo requires mesenchymal cells to form intimate cell-cell contacts and to respond to inductive agents such as transforming factor-beta (TGFb). 1, 5 One of the earliest events during this process is the induction of fibronectin secretion by TGFb. 5, 6 Fibronectin interacts with neural cell adhesion molecule to initiate early chondrogenic events. 5 This accompanies the production of an early matrix that is noncartilaginous in that type I collagen and versican are major components of the ECM. It is not until later that the classical markers of cartilage matrix, type II collagen and aggrecan, appear. 7 These studies provide a platform to better understand dynamics and control issues in in vitro cartilage matrix development.
Toward this goal, adult human mesenchymal stem cells (hMSCs) were induced to differentiate as chondrocytes by following a pathway that is similar that for in vivo chondrogenesis. Condensation of hMSCs can be achieved in a variety of methods, including gentle centrifugation and induction by exposing cells to TGFb1. [8] [9] [10] [11] Additional enhancement of hMSC differentiation resulted from the addition of fibroblast growth factor-2 (FGF-2) to culture medium used for hMSC expansion. 11 Chondrogenesis for aggregate cultures was evident by day 3. Chondrogenic events included significant changes in the production and release of ECM molecules and changes in sulfation patterns of PGs. The chondrogenic process was monitored by establishing a time line for the secretion of ECM molecules in such aggregate cultures. 7 Cultured cells secrete matrix molecules, but only a portion of these molecules become entrapped in an insoluble matrix. Most of these secreted molecules, particularly at early stages, are released into conditioned medium as soluble molecules. 12, 13 This affords the opportunity to apply proteomic methods to follow differentiation events in a non-invasive manner. However, it is first necessary to establish a time line of matrix molecule production by aggregate cultures. This was accomplished through the use of microarray assays to assess mRNA levels for essential matrix molecules. A proof of concept is included where sulfation pattern for chondroitin and keratan sulfate chains were shown to be expressed both in aggregate culture and in conditioned medium.
MATERIALS AND METHODS

Human Bone Marrow Derived Mesenchymal Stem Cells
Adult human iliac crest aspirates from two healthy adult volunteer donors were collected using a procedure reviewed and approved by the University Hospitals of Cleveland Institutional Review Board. Samples were prepared for culture and placed onto tissue culture plastic as previously described. 14 Plated cells were expanded using Dulbecco's Modified Eagle's Medium with low glucose (DMEM-lg) that was supplemented at a 10% level with a selected batch of fetal bovine serum (FBS) and further supplemented with 10 ng/ml basic fibroblast growth factor-2 (FGF-2). 15 
Chondrogenic Differentiation
The hMSCs at first passage were transferred to chondrogenic differentiation medium which consisted of DMEMhigh glucose that was supplemented with 1% InsulinTransferrin-Sodium Selenite medium supplement (BD Bioscience, San Jose, CA), 10 À7 M dexamethasone, 1mM sodium pyruvate, 120 mM ascorbate 2-phosphate, 100 mM non-essential amino acids (all from GIBCO, Waltham, MA), and 10 ng/ml TGFb1 (Peprotech, Rocky Hill, NJ). 10, 11, 15 Aggregates were created by placing 250,000 cells into conical wells of a non-adhesive 96-well plastic plate and centrifuging the plate at low speed. The expansion medium was replaced with differentiation medium and aggregates were harvested for RNA extractions at the following time points: Days 3, 7, 10, 14, 21, and 28. Cultured monolayer hMSCs, before chondrogenic induction (day 0 samples), were included in the analyses.
RNA Extraction
Harvested aggregates were homogenized using RNase-free disposable Aggregate-Pestles (Kimble-Chase, Vineland, NJ) and the extracts were digested on-column with DNase-1 and were then purified using RNeasy mini kit (Quiagen, Hilden, Germany). The RNA concentrations in each sample were determined using a Nanodrop 2000 spectrophotometer (Thermo Fisher, Waltham, MA).
Microarrary Analyses
Whole-genome 16 expressional analyses were carried out using Human Ref-8v3 or Human HT-12 v4 BeadArrays (Illumina, San Diego, CA). Total RNA was linearly amplified with biotin incorporation using Illumina TotalPrep kits (Life Technologies, Carlsbad, CA). The quality of the cRNA was assayed using an Agilent 2100 bioanalyzer (Santa Clara, CA). The resulting cRNA was hybrized to Illumina BeadChips (San Diego, CA), processed and read using a BeadStation array reader (Illumina, San Diego, CA) according to the manufacturer's instructions. Numerical values of relative fluorescence units (RFU) were determined for indicated genes. Values less than 180 units were considered to be background signals. The RFU values for the two donors were averaged and these values were used to determine fold changes with respect to day 0 hMSCs. Tables 1-3 and  supplemental Tables present fold difference at the respective time points.
Histological Preparation and Analyses
Chondrogenic aggregates were prepared as described above. Aggregates and conditioned medium were harvested at indicated time points (days 3, 5, 7, 10, 21). Aggregates were fixed in neutral buffered 3% formalin overnight, washed in phosphate buffered saline, and embedded in paraffin. Sections of aggregates were mounted on slides, deparaffinized, and hydrated for histochemical (toluidine blue) and immunohistochemical assays using monoclonal antibodies specific for CS and KS. 17, 18 The antibodies used for these studies recognize carbohydrate epitopes that are stable using the indicated preparation procedures. The monoclonal antibodies used for the study were obtained from hybridoma supernatants. Hybridoma cells were cultured in RMPI 1640 medium that was supplemented with gentamicin and 15% FBS that was selected for hybridoma growth. Hybridoma medium was applied neat for 1 h. The samples were washed and second antibody, goat anti-mouse IgG, IgA, and IgM conjugated with FITC (Chemicon, now MilliporeSigma, Temecula, CA) was applied for 1 h. Toluidine staining was performed as previous described. 11, 15 Photographs were taken using a Leica DML Microscope (Wetzlar, Germany) using SPOT Image Capture System (Diagnostic Instruments, Sterling Heights, MI) and saved in the TIFF format as RBGimages. Contrast/brightness was modified using Adobe Photoshop. Composite images were prepared using Adobe Illustrator.
Fluorescence-Activated Cell Sorting
Cultures of hMSC were grown to subconfluence in medium supplemented with FGF-2. The cells were detached using 0.25% trypsin-0.20% EDTA (Sigma/Aldrich, ST Louis, MO) and were washed 3Â with Tyrode's solution. These cells were allowed to sit at 25˚C for 1 h before being fixed with 3% formalin in Tyrode's solution. The cells were washed 3Â with Tyrode's solution before being counted and divided into aliquots for immunostaining. Primary antibody hybridoma medium (see below) (4C3 17 , 7D4, 17 6C3, 17 PG-4, 18 CD73 19 ) was added to samples for a 1 h incubation at 37˚C. These samples were washed 3Â with Tyrode's solution and were incubated with secondary anti-mouse IgG/IgM diluted 1/ 1,000 in Tyrode's solution. These samples were incubated at 37˚C in the dark for 1 h, washed 3Â with Tyrode's solution. An aliquot of each sample was taken for visualization as a suspension culture. The remainder of the sample was assayed using BD Accuri 1 C6 digital basic flow cytometer equipped with a BD CSampler (BD Biosciences, San Jose, CA). The sample incubated with the 4C3 antibody was used as a negative control for gating. Each run assayed 10,000,000 counts.
Enzyme-Linked-Immunoabsorbance Assay Preparation and Analyses EIA-plates with 96-wells (Corning Costar, Corning NY) were used for the study. PGs were adsorbed to well by placing 50 ml of conditioned medium into well in triplicate. 18 Medium that was not used for culture served as the control. The plates were incubated at 4˚C overnight, washed 3Â with phosphate buffered saline (PBS) to remove unbound materials and each well was blocked with 100 ml of a solution consisting of 1% bovine serum albumin in PBS for 1-2 h at 25˚C. The wells were washed 6Â with PBS and 50 ml of primary antibody, neat hybridoma medium, was added to each well. The plates were incubated 2 h at 37˚C and washed 6Â to remove unbound antibody. The plates were washed 6Â with PBS and secondary antibody, goat anti-mouse Ig conjugated with alkaline phosphatase, was add 50 ml to each well and incubated 2 h at 37˚C. The plates were washed 6Â and alkaline phosphate substrate, 100 ml was added to each well. The plates were incubated at 25˚C to develop color. The plates were read on a GENios PRO multiplate-reader (Tecan, Durham, NC) using 405 nm absorbance. All readings represent average values from three wells. Purified embryonic chick aggrecan 20 was used as a standard for the PG assay.
Safranin-O Assay
The safranin-O assay was performed as previously described. 15, 20 Briefly, glycosaminoglycans (GAGs) were extracted from aggregates, mixed with the Safranin-O dye, and the bound dye was collected by filtration. The dye was eluted from the filter and the amount was determined calorimetrically. Purified chick aggrecan was used as a standard.
RESULTS Differentiation Stage, Day 3
Compact chondrogenic aggregates are not metachromatic on day 3, but this situation changes by day 7 (Fig. 1) . Actually, changes in GAGs have occurred by day 3; however, their detection requires more sensitive immunohistochemical staining for visualization (Fig. 2) ; both CS and KS are present. KS, which is not expressed by hMSCs is now present (not shown). The antibodies employed in this study 17, 18 do not identify specific PGs; however, microarray data (Table 1) provides an indication of which CS and KS PGs are likely being produced during the initial transition period. Messages for small CS and KS PGs, such as decorin and fibromodulin, are expressed at the early time points as is the message for versican. Matrix molecules other than PGs are also being produced in the early stages of differentiation (Table 2 ). These include: Fibronectin, dermatopontin, cartilage oligomeric protein, type I collagen, type VI collagen, and tenascin-c. In contrast, signature molecules for cartilage, 1,2 type II collagen and aggrecan are not actively expressed initially upon differentiation.
PGs are not restricted to the ECM, but also reside on cell surfaces. 21 This raises the issue of whether initial differentiation of hMSCs (day 0 cells) affects cell surface PGs. The cell surface expression of CS is limited on hMSCs (Fig. 3) . Some CS antibodies such as 4C3 and 7D4 (not shown) do not detect surface PGs, while others such as PG4 and 6C3 (not shown) detect surface PGs on only a limited subset of cells. The 19 was employed as a positive control as it recognizes most hMSCs. This situation is radically changes upon chondrogenic differentiation of hMSCs (Fig. 2) . Now, PGs associated with chondrogenic cells express both the 4C3 and 7D4 epitopes that were not expressed by hMSCs (Fig. 4) . Further, the PG4 and 6C3 epitopes are now expressed by a high percentage of cells (Fig. 2) . The genes for two cell surface PGs, syndecan 4 and CS PG 4 are upregulated on day 3 (Table 1) , both express CS chains. KS is another GAG whose expression is regulated by chondrogenic differentiation. [22] [23] [24] [25] This GAG is not expressed by hMSCs even though core proteins such as fibromodulin and lumican are expressed by these cells (Table 1) . However, upon differentiation the mRNA for these genes and for PRELP, another KSPG are upregulated. Also upregulated on day 3 are genes that code for the glycosyltransferases that create the backbone of KS chains. 22 The beta-1,4-galactosyltransferase 1 (B4GALT1) gene and the beta-1,4-galactosyltransferase 4 (B4GALT4) gene 22 are upregulated 1.8 and 3.2-fold, respectively. In addition, antibodies that specifically identify KS 17 detect antigens in day 3 aggregate cultures ( Fig. 2) . Thus, KS expression is an early marker for chondrogenic differentiation.
Sulfate Metabolism
Enhanced PG synthesis that is initiated during differentiation requires increased levels of sulfate for GAG production. 26, 27 This sulfate upon entering the cell must be transported to the Golgi where GAG synthesis 
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occurs. One of the earliest genes to be upregulated by TGFb is phosphoadenosine 5 0 -phosphosulfate synthase 2 (PAPPS 2) that codes for a sulfate chaperone molecule that transports sulfate to the Golgi apparatus 28 (Tables 1-3 ). This gene is further upregulated on day 14 when PG production is further upregulated. Other genes that are upregulated are SLC26A2, a gene that codes for a membrane sulfate transporter 26 and CHST genes that regulate the sulfation of CS and KS chains. 29 Conditioned Medium Assays Day 3 aggregate cultures appear to contain low levels of sulfated GAGs based upon toluidine blue staining (Fig. 1) ; however, both microarray and immunohistochemical data challenge this interpretation. A partial reason for the apparent low levels of aggregate metachromasia is that substantial sulfated PGs are being released into the conditioned medium (Fig. 5A) . ELISA analyses of this CM confirms that these are both CS and KS PGs (Fig. 5B) . This is consistent with the microarray data presented above.
Maturation Phase, Day 14
The maturation period is where there is substantial upregulation for multiple ECM genes occurs (Tables 1 and 3 ). During normal cartilage development multiple matrix compartments emerge which are characterized by the presence of different sets of PGs 1,2 (Fig. 6 ). Immunohistochemical staining of aggregate cultures for CS and KS also reveals the appearance of distinct compartments (Fig. 7) . Antibody 6C3 17 sees a sulfation motif that appears to be common to all compartments. In contrast, antibody PG-4 18 selectively detects a CS motif that is highly expressed in the pericellular matrix that surrounds chondrocytes and is also found in the territorial matrix. The 7D4 17 antibody is more restrictive in that is sees motifs that are associated with chondrocytes and which are found in the territorial matrix. This patterning of CS motifs is an indication that modifications in gene expression that occur during the maturation phase are creating a cartilage-like matrix (Table 1) .
Sulfate metabolism is critical for the production of PG chains and a significant upregulation of sulfation genes are a component of aggregate maturation (Tables 1 and 2 ). The PAPSS2 gene that was 20 for sulfated GAGs was applied to extracts of aggregate cultures at the indicated stages and upon conditioned media that was harvested from these cultures at the same intervals. (B) Assays were performed to assess the amounts of chondroitin and keratan sulfate proteoglycans in aggregate culture conditioned media. Antibodies PG4 and 6C3 were used to detect chondroitin sulfate and the antibody 8C2 was used to detect keratan sulfate. Embryonic chick aggrecan was used as a standard. These results represent a single sample, N ¼ 1.
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SORRELL ET AL. upregulated on day 3 is further upregulated on day 14. Also upregulated is the solute carrier family 26 member 2 (SLC26A2) gene that codes for a membrane sulfate transporter. [29] [30] [31] [32] [33] These events indicate that more sulfate can enter the cell during this period, a feature that is necessary to accommodate the increased production of PGs. Sulfation of CS and KS chains occurs in the Golgi apparatus where it is mediated by CHST genes. 4, 31 Multiple CHST genes are upregulated on day 14.
Collagens
Collagens, both fibrillar and non-fibrillar varieties, are a major and critical component of cartilage matrices, 34, 35 and they are accompanied by numerous ancillary molecules that regulate fibrillogenesis and matrix organization. 36, 37 Type I and type II collagens that are critical for cartilage matrices 1,2 are both produced in aggregates, but with substantially different mRNA profiles (Table 3) . Type I collagen mRNAs appear early and are further upregulated upon maturation of the matrix. In contrast, type II collagen mRNAs are highly expressed only upon maturation of the matrix. The genes for COMP and nonfibrillar accessory type IX collagens, COL9A1, COL9A2, and COL9A3 are likewise upregulated. 34 Dermatopontin (DPT), a molecule that plays a role in the initiation of collagen fibrillogenesis is also highly upregulated. 34 Type X collagen gene activity is also upregulated. In normal development of long bones, type X collagen expression is primarily confined to hypertrophic chondrocytes at the base of the growth plate. 2 However, in aggregate cultures the expression of this molecule coexists with other collagens. Figure 7 . CS in day 21 aggregate cultures. Sections from the same aggregate culture were immunostained using three different antibodies that detect three different CS sulfation motifs. 17, 18 (6C3) This antibody detects CS more or less equally in all compartments of cartilage matrix. Marked region shows examples of cells, pericellular matrices, territorial and interterritorial regions that are positively immunostained. (PG-4) The marked region shows that this antibody recognizes a sulfation motif that is highly concentrated in the pericellular region and to a lesser extent is present in the territorial matrix. The arrow indicate low expression in the interterritorial matrix. (7D4) The marker region highlights the detection by this antibody of cells and to a lesser extent the territorial matrices that surround these cells. The arrow further indicates the low expression of this sulfation motif in the interterritorial matrix. Bars ¼ 250 mm.
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DISCUSSION
The complex and voluminous ECM of cartilage imparts unique functions to this tissue which makes it important to understanding how this matrix matures in culture. Kinetic analyses of this developmental process have been performed in this study and in other studies. 7, 38 However, it is equally essential to develop a better understanding when and how the actual matrix molecules are being produced and are being integrated into the new evolving matrix. In the current study, microarray data analyses 16 have been used to monitor mRNA expression profiles for multiple matrix molecules. These same data have also been employed in a recent study that compared mRNA activity of cultured aggregates with that for mRNA activity in human neonatal cartilage. 16 Significant differences were observed, an indication that much more work is required to create an effective tissue engineered cartilage. Another recent study from this laboratory has provided additional confirmatory data. In this study, the mRNA profiles for SOX9 and ACAN was assayed by inserting lentiviral reporters into hMSCs and then using these cells for aggregate culture. 39 Live cultures at various time points were assayed for luciferase expression. This resulted in patterns of expression that closely corresponded with the microarray data.
The value of the microarray data is that it affords the opportunity to simultaneously evaluate mRNA expression kinetics for multiple classes of matrix molecules as is presented in the Graphic Abstract. These data can then be analyzed in concert with existing in vivo and in vitro data. It is clear that the initial matrix that is produced in this model is more like that of noncartilaginous tissues in that principal components consist of type I collagen and versican. Fibronectin, a ubiquitous matrix molecule, also plays a role in the early chondrogenic differentiation process. 6 In addition, sulfation, as indicated by the early upregulation of the PAPSS2 gene emphasizes the importance of this process. 4 These early differentiation events lead to a more mature cartilage matrix in this model. Maturation results in the appearance of novel PGs such as epiphycan which is characteristic of articular cartilage. 40 Thus, substantial changes in matrix molecular production during the maturation phase.
Chondrogenic differentiation in aggregate culture requires the exposure of cells to an agent such as TGF-b. 10, 11, 16 Previous studies 28, 41 have shown that two genes that are rapidly upregulated by TGFb are PAPSS2 and PRG4. The current data indicates that these two genes are also upregulated by day 3 of culture. The PAPSS2 gene codes for a sulfate chaperone molecule that transports sulfate to the Golgi. 26, 41 Upon entering the Golgi, sulfate is attached to GAG chains. The upregulation of the PAPSS2 gene signifies a modification of sulfate metabolism within newly differentiated chondrocytes, and a further upregulation coincides with the start of the maturation phase. Consequences of this change are detected by monoclonal antibodies that detect cell surface and matrix alterations that occur both upon differentiation and later during the maturation period. Mutation of the PAPSS2 gene result in severe chondrodysplasia in both humans and mice that results from the undersulfation of CS chains. 4, 42 The PRG4 gene codes for the PG core protein termed lubricin. 30 Lubricin is produced by synovial cells in mature joints. In aggregate cultures, it appears to be produced by cells that have fibroblast-like phenotype, possibly a transitional cell. 43 In the current cultures, lubricin is transiently produced and does not appear to play a significant role in aggregate development. The modification of sulfation motifs as observed in the current study have been shown to be critical for manner in which cells see and respond to their environment. Stem cells upon differentiation modify sulfation motifs differently to match the direction of their differentiation. 44 Archer and co-workers identified a subpopulation of cells in the resting zone of articular cartilage that upon isolation exhibit chondrogenic stem cell characteristics. 45 Caterson's group further characterized these cells as expressing the sulfation motifs for 3B3-minus, 4C3, and 7D4 antibodies. 46 These motifs are not expressed on hMSCs, but upon chondrogenic differentiation of these cells they become expressed. This does not necessarily identify these cells as stem cells, but it does indicate a significant modification in sulfate pattern that is induced by differentiation. Two cell surface core protein genes were upregulated upon differentiation, SDC4 and CSPG4. 47 It is not currently clear to what extent this has upon sulfation motifs. Another factor is the expression of sulfotransferases, enzymes that mediate the attachment of sulfate to GAG chains. 4, 28, 31 A family of Keratan sulfate is a GAG that is restricted to only a few tissues such as the central nervous system, corneal stroma, and cartilage. 22 This GAG, in its sulfated form, is not produced by hMSCs; however, upon differentiation as chondrocytes it is expressed as a sulfated GAG. The genes for three PG core proteins that bear this GAG, lumican, fibromodulin, and PRELP are also upregulated. Immunohistochemical analyses of hMSCs and day 3 aggregates indicates that sulfated KS appears as a differentiation marker.
The initial ECM upon differentiation is decidedly noncartilage-like in that the principal components are fibronectin, type I collagen, and versican. 6, 34, 48, 49 It is during the later maturation period that a more cartilage-like matrix begins to form; this includes type II collagen and aggrecan. Furthermore, this later period is where a significant upregulation in genes that are necessary for the production of molecules that participate in type II collagen fibrillogenesis occurs. In combination, this leads to the appearance of a cartilage matrix in mature aggregates by day 20 of culture. These aggregates contain the four distinct structural domains that have been described for authentic hyaline cartilage. 2 Matrix assembly in culture is an inefficient process, particularly in early cultures. Consequently, a substantial portion of matrix molecules enter the surrounding medium. This provides the opportunity to perform semi-quantitative and/or quantitative assays to monitor matrix production, and the evolution of the cultured tissue without disturbing the developmental process. Such non-invasive assays can be performed upon conditioned medium that is routinely collected when medium is replaced. There are a large number of potential matrix molecules that were assembled during this model chondrogenic process. Therefore, it is necessary to obtain a base of information to determine which matrix molecules should be selected for this purpose. Table 4 provides a time-line for chondrogenic aggregate cultures. These data are based upon messenger RNA levels, not upon protein levels. Nonetheless, they provide a guide as to which matrix molecules might be suitable for such assays. A proof of principal assay has been incorporated into the current study.
In short, chondrogenesis initiated from hMSCs follow a pattern of progression that has been observed in other studies. 7, 38 In this lab, a biphasic response to FGF-9 and FGF-18 was observed at early time-points (day 7 or earlier) than at later time-points. 15 In a similar manner Bradley and Drissi 37 observed differential responses to Wnt-5a when provided at early and later time-points. In both situations, the appearance of type X collagen was suppressed. Under normal conditions, type X collagen expression, which denotes hypertrophy, normally appears in aggregate cultures at or slightly before day 14 of culture. This indicates that the chondrocytes at this time-point are physiological different from their early precursors. This also emphasizes the point that aggregate cultures do not fully replicate the fabrication sequence necessary for the formation of articular cartilage.
